![Simon Read](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Simon Read
Chief Tech/Sci/R&D Officer at
RA PHARMACEUTICALS, INC.
Net worth: - $ as of 2026-06-29
Profile
Simon Read was the founder of Mariana Oncology, Inc., founded in 2021, where the title held was President, Chief Executive Officer & Director.
Dr. Read is also the founder of TRIANA Biomedicines, Inc...
Dr. Read is an Independent Director at Dianthus Therapeutics, Inc. since 2025.
Dr. Read is a Member of The Medical Research Council since 2012.
Dr. Read is Chief Scientific Officer at RA Pharmaceuticals, Inc. since 2016.
Dr. Read is an Advisor at Atlas Venture Advisors, Inc. Dr. Read is a Scientific Advisory Board Member at Q32 Bio Operations, Inc. since 2021.
Dr. Read was Director-Experimental Medicine & Biomarkers at Genentech, Inc. from 2008 to 2011.
Dr. Read was Associate Director Disease at AstraZeneca LP from 2004 to 2008.
Dr. Read was VP & Head-Innovative Medicines Unit at Grünenthal GmbH from 2014 to 2016.
Dr. Read completed undergraduate studies at The University of Manchester.
Dr. Read completed graduate studies at The University of Southampton.
Dr. Read completed a doctorate at the University of Hertfordshire.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-20 | 0 ( -.--% ) | - $ | 2026-06-29 |
Simon Read active positions
| Companies | Position | Start |
|---|---|---|
| RA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2016-04-03 |
| DIANTHUS THERAPEUTICS, INC. | Director/Board Member | 2025-05-21 |
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services Provides human healthcare and social services | Corporate Officer/Principal | 2011-12-31 |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Consultant / Advisor | 2020-12-31 |
Former positions of Simon Read
| Companies | Position | End |
|---|---|---|
Santi Therapeutics, Inc.
 Santi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics to treat diseases | Founder | 2024-01-31 |
Grünenthal GmbH
 Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Manufactures medicines for pain management and related diseases | Corporate Officer/Principal | 2015-12-31 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 2010-12-31 |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Private Equity Investor | 2008-01-01 |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░ | - |
Training of Simon Read
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
75
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
The Medical Research Council
The Medical Research Council Miscellaneous Commercial ServicesCommercial Services Provides human healthcare and social services | Commercial Services |
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of glomerulonephritis, kidney disease and cardiovascular disease | Health Technology |
Grünenthal GmbH
Grünenthal GmbH Pharmaceuticals: MajorHealth Technology Manufactures medicines for pain management and related diseases | Health Technology |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
The University of Southampton
 The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Hertfordshire
 University of Hertfordshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Health Technology |
Santi Therapeutics, Inc.
Santi Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics to treat diseases | Health Technology |
Mariana Oncology, Inc.
 Mariana Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer | Health Technology |
Dianthus Therapeutics, Inc.
 Dianthus Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for patients with autoimmune and inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Simon Read
